Freshpet (NASDAQ:FRPT) PT Lowered to $110.00

Freshpet (NASDAQ:FRPTGet Rating) had its target price decreased by equities researchers at Oppenheimer from $120.00 to $110.00 in a research report issued on Tuesday, The Fly reports. Oppenheimer’s price objective points to a potential upside of 18.15% from the stock’s current price.

Other equities research analysts also recently issued reports about the stock. Citigroup dropped their price objective on shares of Freshpet from $80.00 to $72.00 in a report on Tuesday. The Goldman Sachs Group raised shares of Freshpet from a “neutral” rating to a “buy” rating and upped their price objective for the company from $111.00 to $136.00 in a report on Tuesday, March 29th. Cowen dropped their price objective on shares of Freshpet from $229.00 to $182.00 in a report on Monday, January 10th. Benchmark started coverage on shares of Freshpet in a report on Wednesday, April 27th. They issued a “buy” rating and a $135.00 price target on the stock. Finally, Zacks Investment Research downgraded shares of Freshpet from a “hold” rating to a “strong sell” rating in a report on Monday, March 7th. Two research analysts have rated the stock with a sell rating, one has given a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $141.50.

NASDAQ FRPT opened at $93.10 on Tuesday. The company has a market cap of $4.04 billion, a PE ratio of -134.93 and a beta of 0.73. Freshpet has a 52 week low of $78.81 and a 52 week high of $186.98. The firm’s 50-day simple moving average is $101.23 and its two-hundred day simple moving average is $106.10.

Freshpet (NASDAQ:FRPTGet Rating) last released its quarterly earnings data on Monday, May 2nd. The company reported ($0.40) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.36) by ($0.04). Freshpet had a negative net margin of 6.98% and a negative return on equity of 4.12%. During the same quarter in the previous year, the company earned ($0.26) EPS. As a group, equities research analysts expect that Freshpet will post -0.46 EPS for the current fiscal year.

Several hedge funds have recently bought and sold shares of FRPT. Morgan Stanley increased its position in shares of Freshpet by 152.3% in the second quarter. Morgan Stanley now owns 180,188 shares of the company’s stock worth $29,365,000 after purchasing an additional 108,775 shares during the last quarter. Treasurer of the State of North Carolina increased its position in shares of Freshpet by 3.5% in the third quarter. Treasurer of the State of North Carolina now owns 14,699 shares of the company’s stock worth $2,097,000 after purchasing an additional 499 shares during the last quarter. Shell Asset Management Co. bought a new position in shares of Freshpet in the third quarter worth approximately $274,000. PNC Financial Services Group Inc. increased its position in shares of Freshpet by 9.4% in the third quarter. PNC Financial Services Group Inc. now owns 2,086 shares of the company’s stock worth $297,000 after purchasing an additional 179 shares during the last quarter. Finally, Swiss National Bank increased its position in shares of Freshpet by 0.5% in the third quarter. Swiss National Bank now owns 95,550 shares of the company’s stock worth $13,634,000 after purchasing an additional 500 shares during the last quarter.

About Freshpet (Get Rating)

Freshpet, Inc manufactures and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe. The company sells its products under the Freshpet brand; and Dognation and Dog Joy labels through various classes of retail, including grocery, mass, club, pet specialty, and natural, as well as online.

See Also

The Fly logo

Analyst Recommendations for Freshpet (NASDAQ:FRPT)

Receive News & Ratings for Freshpet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Freshpet and related companies with MarketBeat.com's FREE daily email newsletter.